NIRAMAI Health Analytix Pvt. Ltd., a woman-owned incubator, has awarded The World Bank Group and the Consumer Technology Association's Global Women's Health Tech Awards, which recognise innovative start-ups that utilise technology to advance women's health and safety in developing nations. The Department of Biotechnology's Biotechnology Industry Research Assistance Council (DBT-BIRAC) is supporting the firm.
According to the World Bank, this year's prizes featured more than 70 businesses from 35 countries that presented innovative solutions in three categories: general women's and adolescent health, reproductive health and pregnancy, and women's safety and security.
The BIRAC Women in Entrepreneurial Research Award 2019 was given to NIRAMAI Health Analytix Pvt. Ltd for its innovative software-based medical device that detects early-stage breast cancer and breast densities in women of all ages in a simple and private manner, addressing a critical unmet need in cancer screening.
Dr. Geeta Manjunath, the company's founder, founded NIRAMAI to develop a groundbreaking AI solution for identifying early stage breast cancer in a non-invasive, radiation-free method.
Thermalytix, a computer diagnostic engine based on machine learning and artificial intelligence, uses artificial intelligence algorithms to analyse thermal images and generate a statistical report for breast health and abnormalities.
Dr. Manjunath said, “we are pleased to receive this recognition from the World Bank. It's a validation of the applicability of our Indian innovation to the world.”
The startup's partnerships with more than 30 hospitals and diagnostic centres throughout India have resulted in the testing of over 45,000 women.
The Ministry of Science and Technology said, “the product can help two billion women in the world to regularly screen for cancer and can potentially save 90,000 lives every year in India alone.”